$MNOV
MEDICINOVA INC

2014 Q1 Form 10-K Financial Statement

#000119312514118744 Filed on March 27, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013
Revenue $0.00 $6.000M $3.257K
YoY Change -100.0% 17547.06% -99.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.620M $1.630M $6.660M
YoY Change -5.81% -2.98% -1.04%
% of Gross Profit
Research & Development $600.0K $940.0K $2.700M
YoY Change 20.0% 20.51% -40.0%
% of Gross Profit
Depreciation & Amortization $10.28K $10.00K $100.5K
YoY Change -69.38% -66.67% 44.53%
% of Gross Profit
Operating Expenses $2.364K $2.573M $10.02M
YoY Change -99.9% 4.81% -14.68%
Operating Profit -$2.364M -$4.021M
YoY Change -2.22% -63.27%
Interest Expense $123.00 -$10.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0%
Pretax Income -$2.351M $3.410M -$4.024M
YoY Change -2.86% -240.33% -63.25%
Income Tax $1.543K $0.00 $4.035K
% Of Pretax Income 0.0%
Net Earnings -$2.352K $3.413M -$4.029M
YoY Change -99.9% -240.22% -63.25%
Net Earnings / Revenue 56.88% -123688.3%
Basic Earnings Per Share $0.15
Diluted Earnings Per Share -$99.16K $0.14 -$194.7K
COMMON SHARES
Basic Shares Outstanding 24.07M shares 22.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.80M $6.700M $6.700M
YoY Change 393.33% 67.5% 67.5%
Cash & Equivalents $14.78M $6.700M $6.700M
Short-Term Investments
Other Short-Term Assets $1.300M $1.700M $1.700M
YoY Change 85.71% 325.0% 325.0%
Inventory
Prepaid Expenses
Receivables $6.000M $6.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $16.06M $14.38M $14.40M
YoY Change 332.63% 225.24% 227.27%
LONG-TERM ASSETS
Property, Plant & Equipment $75.79K $82.41K $100.0K
YoY Change 8.42% 5.02% 0.0%
Goodwill $9.600M $9.600M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $700.0K $700.0K $700.0K
YoY Change 0.0% 0.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $15.16M $15.16M $15.10M
YoY Change 0.15% 0.12% -0.66%
TOTAL ASSETS
Total Short-Term Assets $16.06M $14.38M $14.40M
Total Long-Term Assets $15.16M $15.16M $15.10M
Total Assets $31.22M $29.55M $29.50M
YoY Change 65.65% 50.99% 50.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.9K $33.89K $0.00
YoY Change -42.98% -93.11% -100.0%
Accrued Expenses $435.7K $240.1K $400.0K
YoY Change 0.88% -23.68% -20.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $901.8K $460.4K $500.0K
YoY Change -4.89% -55.63% -50.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.700M $1.700M $1.700M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $1.700M $1.700M $1.700M
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $901.8K $460.4K $500.0K
Total Long-Term Liabilities $1.700M $1.700M $1.700M
Total Liabilities $4.567M $4.120M $4.100M
YoY Change -0.67% -12.11% -12.77%
SHAREHOLDERS EQUITY
Retained Earnings -$303.7M -$301.4M
YoY Change 1.7% 1.37%
Common Stock $24.09K $22.50K
YoY Change 31.92% 29.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 0.000 shares
Shareholders Equity $26.65M $25.43M $25.40M
YoY Change
Total Liabilities & Shareholders Equity $31.22M $29.55M $29.50M
YoY Change 65.65% 50.99% 50.51%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$2.352K $3.413M -$4.029M
YoY Change -99.9% -240.22% -63.25%
Depreciation, Depletion And Amortization $10.28K $10.00K $100.5K
YoY Change -69.38% -66.67% 44.53%
Cash From Operating Activities $4.770M -$4.030M -$10.65M
YoY Change -281.93% 84.86% -10.27%
INVESTING ACTIVITIES
Capital Expenditures $3.523K -$40.00K $41.55K
YoY Change -50.16%
Acquisitions
YoY Change
Other Investing Activities $0.00 $20.00K $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$20.00K -$36.75K
YoY Change -100.0% -95.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.984M
YoY Change 83.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.320M 70.00K 13.37M
YoY Change 102.98% -84.78% 765.29%
NET CHANGE
Cash From Operating Activities 4.770M -4.030M -10.65M
Cash From Investing Activities 0.000 -20.00K -36.75K
Cash From Financing Activities 3.320M 70.00K 13.37M
Net Change In Cash 8.090M -3.980M 2.687M
YoY Change -924.28% 131.4% -124.25%
FREE CASH FLOW
Cash From Operating Activities $4.770M -$4.030M -$10.65M
Capital Expenditures $3.523K -$40.00K $41.55K
Free Cash Flow $4.766M -$3.990M -$10.69M
YoY Change -281.79% 83.03% -10.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
130000 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.88
CY2012Q3 mnov Class Of Warrant Or Right Fair Value
ClassOfWarrantOrRightFairValue
100000
CY2012Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30 pure
CY2012Q1 mnov Equity Method Investment Third Party Percentage
EquityMethodInvestmentThirdPartyPercentage
0.70 pure
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24070943 shares
CY2013Q2 dei Entity Public Float
EntityPublicFloat
48678000
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
2500000
CY2012Q3 mnov Other Asset Amortization Period
OtherAssetAmortizationPeriod
P1Y
CY2012Q3 mnov Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
23497546
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15093124
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17407311 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
220000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.92
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3328981 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17403125 shares
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1694257
CY2012Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1956000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1037792
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-67957
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
228124
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
672301
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
94504
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
312293225
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
491853
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
68102
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95474000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
14879992
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-297320178
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3163
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1956000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
2200
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4186 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
314652
CY2012Q4 us-gaap Liabilities
Liabilities
4688049
CY2012Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
0
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
17407
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19568041
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1956000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
83092000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
95474000
CY2012Q4 us-gaap Goodwill
Goodwill
9600241
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1861000
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
170386
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
93518000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
750775
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1554000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
44705
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
667204
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78474
CY2012Q4 us-gaap Assets
Assets
19568041
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4010530
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
351992
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1956000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7145000
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
228397
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
411592
CY2012Q4 us-gaap Assets Current
AssetsCurrent
4422122
CY2012Q4 mnov Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
152046
CY2012Q4 mnov Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
1822000
CY2012Q4 mnov Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
314652
CY2012Q4 mnov Cash Equivalents Money Market Funds
CashEquivalentsMoneyMarketFunds
3900000
CY2012Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22495443 shares
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12025188 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
220000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2196688 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.06
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3217043 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.09
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22495443 shares
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1694163
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1956000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
260213
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
460435
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80803
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
186393
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
431193
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
102094
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
326868578
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
773635
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
33894
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
38208
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
139608
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
96778000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
25425756
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301386714
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1956000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
2200
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240148
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
206441
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013Q4 us-gaap Liabilities
Liabilities
4120487
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
167373
CY2013Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
9889
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
22495
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29546243
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1956000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
84537000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
96778000
CY2013Q4 us-gaap Goodwill
Goodwill
9600241
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1763000
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
16854
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
94822000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
513607
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1454000
CY2013Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
680982
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82414
CY2013Q4 us-gaap Assets
Assets
29546243
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6700493
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
257945
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1956000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7448000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
144
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
144
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
238808
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2000000
CY2013Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1673560
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
6008553
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14382606
CY2013Q4 mnov Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
99846
CY2013Q4 mnov Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
1576000
CY2013Q4 mnov Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
15000 shares
CY2013Q4 mnov Deferred Rent Non Current
DeferredRentNonCurrent
9889
CY2013Q4 mnov Working Capital Net
WorkingCapitalNet
13900000
CY2013Q4 mnov Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
240148
CY2013Q4 mnov Cash Equivalents Money Market Funds
CashEquivalentsMoneyMarketFunds
6000000
CY2013Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2012Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
680000
CY2011Q4 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
2500000
CY2012Q3 mnov Class Of Warrant Or Rights Exercisable Period From Date Of Issuance
ClassOfWarrantOrRightsExercisablePeriodFromDateOfIssuance
P15M
CY2007 mnov Percentage Of Employee Compensation For Purchase Of Common Stock Under Espp
PercentageOfEmployeeCompensationForPurchaseOfCommonStockUnderEspp
Cannot exceed 15%
CY2007 mnov Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M
CY2007 mnov Common Stock Fair Market Value Percentage
CommonStockFairMarketValuePercentage
0.85 pure
CY2013 dei Trading Symbol
TradingSymbol
MNOV
CY2013 dei Entity Registrant Name
EntityRegistrantName
MEDICINOVA INC
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001226616
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2013 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P4Y9M
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
30251 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.42
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.022 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.075 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.637 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20697440 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.37
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10646456
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
79462 shares
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i>Concentrations and Credit Risk</i></b></p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company maintains cash balances at various financial institutions and such balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company also maintains money market funds at various financial institutions which are not federally insured although are invested primarily in U.S. government securities. The Company has not experienced any losses in such accounts and management believes that the Company does not have significant credit risk with respect to such cash and cash equivalents.</p> </div>
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 12pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201C;GAAP&#x201D;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2013 us-gaap Licenses Revenue
LicensesRevenue
6000000
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.036 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.29
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.200 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9178110 shares
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.44
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1608000 shares
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2013 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-3257
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1640476 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2013 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13778
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41554
CY2013 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
3000.0
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4048522
CY2013 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
20565
CY2013 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
259690
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1216444
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2689963
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2013 us-gaap Operating Expenses
OperatingExpenses
10023797
CY2013 us-gaap License Costs
LicenseCosts
700000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4035
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2479
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193951
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
6354
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4028528
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
24029
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
3257
CY2013 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
12687125
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4024493
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12846
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1216444
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1353334
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4041374
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-4020540
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4307
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6008553
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-4028528
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56487
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2013 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
24518
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-41730
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6657989
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13370694
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
87710
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4800
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100487
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4035
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4035
CY2013 us-gaap Depreciation
Depreciation
36655
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36754
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2700000
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13363997
CY2013 mnov Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2017-11
CY2013 mnov Capital Loss Carryforward Expiration Year
CapitalLossCarryforwardExpirationYear
2015
CY2013 mnov Proceeds Or Payments For Issuance Or Repurchase Of Common Stock Net
ProceedsOrPaymentsForIssuanceOrRepurchaseOfCommonStockNet
6697
CY2013 mnov Cumulative Stock Ownership Change Period
CumulativeStockOwnershipChangePeriod
P3Y
CY2013 mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
-509900
CY2013 mnov Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
63704000000
CY2013 mnov Warrant Exercises
WarrantExercises
433131
CY2013 mnov Employee Stock Purchase Plan Number Of Shares Available For Issuance
EmployeeStockPurchasePlanNumberOfSharesAvailableForIssuance
234327 shares
CY2013 mnov Increase In Ownership Percentage
IncreaseInOwnershipPercentage
0.50 pure
CY2013 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.003 pure
CY2013 mnov Proceeds From Issuance Of Private Placement Net
ProceedsFromIssuanceOfPrivatePlacementNet
3400000
CY2013 mnov Research Development And Patents Expense
ResearchDevelopmentAndPatentsExpense
3365808
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.283 pure
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16522929 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.33
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11864438
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.126 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8657667 shares
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
750000 shares
CY2012 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-802580
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1348873
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83378
CY2012 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
800000
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
100000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10986343
CY2012 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
24791
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
137730
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
10951
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10961314
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
36173
CY2012 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
680000
CY2012 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
802580
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10950170
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11112
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
709650
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-266927
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10972426
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-10945356
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-823
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-10961314
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
58619
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2012 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
29605
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-370964
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6734844
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1545222
CY2012 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
286762
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
709650
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11082594
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2012 us-gaap Operating Expenses
OperatingExpenses
11747936
CY2012 us-gaap License Costs
LicenseCosts
500000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11144
CY2012 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
96415
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69528
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11144
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
11144
CY2012 us-gaap Depreciation
Depreciation
33507
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-763378
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4500000
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1486603
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2786000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2786000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
2788000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2379000
CY2012 mnov Proceeds Or Payments For Issuance Or Repurchase Of Common Stock Net
ProceedsOrPaymentsForIssuanceOrRepurchaseOfCommonStockNet
58619
CY2012 mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
-776508
CY2012 mnov Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
61620000000
CY2012 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.001 pure
CY2012 mnov Research Development And Patents Expense
ResearchDevelopmentAndPatentsExpense
5013092
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2419000
CY2013Q1 us-gaap Revenues
Revenues
3000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-2419000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
2421000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3867000
CY2012Q1 us-gaap Revenues
Revenues
191000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-3867000
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
4064000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2281000
CY2012Q2 us-gaap Revenues
Revenues
494000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2281000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
2781000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2012Q3 us-gaap Revenues
Revenues
84000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-2379000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
2446000
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2237000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2237000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2242000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2434000
CY2012Q4 us-gaap Revenues
Revenues
34000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-2434000
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
2455000
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3413000
CY2013Q4 us-gaap Revenues
Revenues
6000000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
3413000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
2573000

Files In Submission

Name View Source Status
0001193125-14-118744-index-headers.html Edgar Link pending
0001193125-14-118744-index.html Edgar Link pending
0001193125-14-118744.txt Edgar Link pending
0001193125-14-118744-xbrl.zip Edgar Link pending
d652763d10k.htm Edgar Link pending
d652763dex1023.htm Edgar Link pending
d652763dex231.htm Edgar Link pending
d652763dex311.htm Edgar Link pending
d652763dex321.htm Edgar Link pending
d652763dex48.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g652763g65c93.jpg Edgar Link pending
g652763g77z87.jpg Edgar Link pending
mnov-20131231.xml Edgar Link completed
mnov-20131231.xsd Edgar Link pending
mnov-20131231_cal.xml Edgar Link unprocessable
mnov-20131231_def.xml Edgar Link unprocessable
mnov-20131231_lab.xml Edgar Link unprocessable
mnov-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending